Home » Topics » Disease categories and therapies » Ocular

Ocular
RSS

News from ARVO: antiglaucoma activity of p160ROCK kinase inhibitor

May 3, 2000

Chiron team identifies promising treatment for retinitis pigmentosa

May 3, 2000

New formulations of carteolol may reduce dosing frequency

May 2, 2000

IOP-lowering efficacy of anecortave established in preclinical models and in patients

May 2, 2000

AMPA antagonist improves visual function in humans

May 2, 2000

New chemical class with dual mechanism of action presented as promising glaucoma therapeutics

May 2, 2000

ADL-2-1294 licensed to Santen for ophthalmic indications

April 28, 2000

CPMP recommends European approval of Visudyne for wet AMD

April 19, 2000

FDA approves Visudyne therapy for treatment of AMD

April 13, 2000

Interferon alfa-2b offers protection from eye involvement in Behcet's disease

April 13, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 5, 2026.
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Slate Medicines launches with focus on headache disorders
BioWorld Science
Slate Medicines Inc. has launched with $130 million in series A financing and a focus on advancing next-generation therapeutics for migraine and other headache...